• Empowering Wellness...

Bevatas 400mg Injection in Egypt

Bevatas 400mg Injection

SKU: BEVATAS-400MG-INJECTION
$533.77$143.93
CategoriesAnti-Cancer
Manufacturer/Marketed ByINTAS PHARMACEUTICALS LTD
Inquiry on WhatsApp

Active Pharmaceutical Ingredient

Bevacizumab 400 mg

Product Information

Bevatas 400mg Injection is a pharmaceutical product available for international pharmaceutical supply. Siddha Global is an India-based pharmaceutical exporter serving international buyers, importers, distributors and pharmaceutical companies.

We accept enquiries for Bevatas 400mg Injection for Egypt, subject to product availability and applicable regulatory and import requirements.

For pricing, availability and bulk supply, contact Siddha Global with your required quantity and procurement details.

Bevatas 400mg Injection Supplier for Egypt

Siddha Global supplies pharmaceutical products to international markets and accepts enquiries from qualified pharmaceutical buyers in Egypt.

We work with:

  • Pharmaceutical importers
  • Pharmaceutical distributors
  • Pharmaceutical wholesalers
  • Hospitals and healthcare organizations
  • Pharmaceutical companies
  • Authorized procurement organizations

Buyers can contact us for Bevatas 400mg Injection availability, pricing and bulk supply requirements.

Buy Bevatas 400mg Injection for Egypt

If you are looking to source Bevatas 400mg Injection in Egypt, send us your requirements.

Please provide:

  • Required quantity
  • Product name and strength
  • Destination country: Egypt
  • Packaging requirements
  • Delivery requirements

Our team will review your enquiry and provide relevant product and commercial information.

Why Choose Siddha Global?

Pharmaceutical Exporter from India

Siddha Global is an India-based pharmaceutical exporter supplying pharmaceutical products to international markets.

International Pharmaceutical Supply

We support pharmaceutical sourcing requirements for importers, distributors and other qualified international buyers.

Bulk Pharmaceutical Orders

We accept enquiries for bulk pharmaceutical requirements based on product availability and applicable market requirements.

Export Support

We assist international buyers with relevant commercial and export requirements for pharmaceutical orders.

Frequently Asked Questions

What is Bevatas 400mg Injection?

Bevatas 400mg Injection is a pharmaceutical injection available in a 400mg strength for international pharmaceutical sourcing.

Is Bevatas 400mg Injection available in Egypt?

Siddha Global accepts enquiries for Bevatas 400mg Injection supply to Egypt, subject to product availability and applicable Egyptian regulatory and import requirements.

What is the strength of Bevatas Injection?

Bevatas Injection is available in a 400mg strength.

Can I order Bevatas 400mg Injection in bulk?

Yes. Qualified pharmaceutical importers, distributors and other authorized buyers can submit bulk requirements to Siddha Global for availability and commercial information.

How can I request a quotation for Bevatas 400mg Injection?

Send us your required quantity, destination country and packaging requirements. Our team can review your enquiry and provide relevant quotation information.

Who can enquire about Bevatas 400mg Injection?

Pharmaceutical importers, distributors, wholesalers, healthcare organizations and other appropriately authorized organizations can contact Siddha Global regarding pharmaceutical procurement.

Request a Quote for Bevatas 400mg Injection

Looking for Bevatas 400mg Injection in Egypt?

Contact Siddha Global for product availability, pricing and bulk pharmaceutical supply enquiries.

• Glioblastoma multiforme (brain cancer) • Persistent, recurrent, or metastatic breast cancer • Metastatic cervical cancer • Advanced kidney cancer • Metastatic colorectal cancer • Advanced non-small-cell lung cancer • Liver Cancer- Hepatocellular carcinoma • Cancers of the ovary, cervical, fallopian tube, or primary peritoneal cancer

Bevatas 400mg Injection is a recombinant humanized monoclonal antibody that works as a targeted therapy in the treatment of various advanced cancers. It produces its action by selectively binding to the protein called vascular endothelial growth factor A (VEGF-A), present in the lining of blood and lymph vessels in the body. It interrupts the interaction of VEGF-A with its receptors. This further inhibits the formation of blood vessels that supply oxygen and nutrients to the tumor. As a result, it slows down the rate of progression of cancer.

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.

• Numbness in hands or feet • Weakness and lack of energy • Diarrhoea, nausea, vomiting, abdominal pain • Constipation • Loss of appetite • Weight loss • Changes in taste and speech • Decrease in counts of white blood cells • Fever • Dry skin • Back pain

Your physician or nurse will administer Bevatas 400mg Injection as an intravenous infusion. The infusion should be given immediately after the dilution.

• Breast Feeding: It is recommended to avoid breastfeeding for a minimum of 6 months after your treatment with Bevatas 400mg Injection as this medicine may interfere with the growth of your child. • Alcohol: Consult your doctor to know if it is safe to consume alcohol while you are on treatment with Bevatas 400mg Injection as only limited studies are available. • Liver: Inform your physician before starting Bevatas 400mg Injection if you have liver diseases to avoid any serious side effects. • Lungs: Inform your doctor if you have any lung conditions before starting treatment with Bevatas 400mg injection • Driving: Avoid driving or using machinery while you are on your treatment with Bevatas 400mg Injection as it is related to cause dizziness or sleepiness. • Pregnancy: Inform your physician before starting your treatment with Bevatas 400mg Injection in case, if you are pregnant or planning for pregnancy as this medicine may cause harm to the unborn baby and interrupt the formation of blood vessels.
Chat with Siddha Global on WhatsApp